Antares Pharma, Inc. (ATRS)

CapEx to Revenue

0.19%

Quarterly · Period ending:

ATRS logo

ATRS CapEx to Revenue

Latest reported0.19%
ATRS Quarterly CapEx/Revenue (0.00% → 0.19%)
High-resolution chart · PNG

ATRS capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
10%
16.0095%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.